Insider Selling Signals Market Caution for AtriCure Investors The latest SEC filing reveals that Maggie Yuen, director at AtriCure, Inc. , has significantly reduced her stake in the company's common stock.
On August 5, 2026, Yuen sold 3,500 shares of ATRC, bringing her total beneficial ownership to 14,015 shares – a reduction of 20% from her previous position.
Yuen's decision to sell may seem counterintuitive given AtriCure's recent financial performance. The company has consistently demonstrated strong revenue growth, with $569.